Mechanisms of cytokine synergy essential for vaccine protection against viral challenge

The ability of cytokines to steer CD4+ Th cell responses toward a Th1 or Th2 phenotype and enhance the magnitude of both CD8+ cytotoxic T lymphocytes (CTL) and antibody responses has clearly been demonstrated by our lab and others, but the influence of cytokines on protective immune responses is muc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunology 2001-07, Vol.13 (7), p.897-908
Hauptverfasser: Ahlers, Jeffrey D., Belyakov, Igor M., Matsui, So, Berzofsky, Jay A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 908
container_issue 7
container_start_page 897
container_title International immunology
container_volume 13
creator Ahlers, Jeffrey D.
Belyakov, Igor M.
Matsui, So
Berzofsky, Jay A.
description The ability of cytokines to steer CD4+ Th cell responses toward a Th1 or Th2 phenotype and enhance the magnitude of both CD8+ cytotoxic T lymphocytes (CTL) and antibody responses has clearly been demonstrated by our lab and others, but the influence of cytokines on protective immune responses is much less clear. Here we show an essential role for CD4+ Th1 helper cell induction and IFN-γ production in protection from viral challenge with a recombinant vaccinia virus expressing HIV-1MN viral envelope glycoprotein gp160. Complete protection from viral challenge is achieved only when the triple combination of exogenous cytokines granulocyte macrophage colony stimulating factor (GM-CSF), IL-12 and tumor necrosis factor (TNF)-α are co-administered with the peptide vaccine. In vivo depletion of CD4+ cells or immunization of IFN-γ-deficient mice abrogates protection. GM-CSF, IL-12 and TNF-α also synergize for the enhanced induction of CTL; however, adoptive transfer of a CD8+ CTL line afforded only partial protection in this viral challenge model. As a possible mechanism of in vivo protection we show that GM-CSF increases the percentage and activity of antigen-presenting dendritic cells in draining lymph nodes where the immune response is initiated. We further demonstrate synergy between IL-12 and the proinflammatory cytokine TNF-α in driving IFN-γ production. Thus, a combination of IL-12 and TNF-α is essential for the optimal development of Th1 responses and help for CTL induction in BALB/c mice, and is complemented by a third cytokine, GM-CSF, which enhances antigen presentation.
doi_str_mv 10.1093/intimm/13.7.897
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70971755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18085142</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-4098071464cd8cc769ca0f7b1b1f91f27934cadf3748e0795c3e4732c9b86ca13</originalsourceid><addsrcrecordid>eNqFkc1vEzEQxS0EomnhzA2tOPS2iWdtZ-wjjUqDSFUhgUBcLMeZDW53va29qch_j6tEIHHhNIf3mzcfj7E3wKfAjZiFOIa-n4GY4lQbfMYmIOe8bgTiczbhRolaA-oTdprzLedcNEa8ZCcAUoBs-IR9uyb_08WQ-1wNbeX343AXIlV5Hylt9xXlTGWG66p2SNWj8_5JvU_DSH4MQ6zc1oWYx-oxpAIVr66juKVX7EXrukyvj_WMff1w-WWxrFc3Vx8X71e1l8qMteRGcyw7S7_R3uPceMdbXMMaWgNtg0ZI7zatQKmJo1FekETReLPWc-9AnLHzg29Z6WFHebR9yJ66zkUadtkiNwio1H9B0Fyr8pMCvvsHvB12KZYjLBjFhRLKFGh2gHwack7U2vsUepf2Frh9SsYekrEgLNqSTOl4e7TdrXva_OWPURSgPgAhj_Trj-7SnZ2jQGWX339YfQHLT4vVZ3shfgOaeJpK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195035359</pqid></control><display><type>article</type><title>Mechanisms of cytokine synergy essential for vaccine protection against viral challenge</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ahlers, Jeffrey D. ; Belyakov, Igor M. ; Matsui, So ; Berzofsky, Jay A.</creator><creatorcontrib>Ahlers, Jeffrey D. ; Belyakov, Igor M. ; Matsui, So ; Berzofsky, Jay A.</creatorcontrib><description>The ability of cytokines to steer CD4+ Th cell responses toward a Th1 or Th2 phenotype and enhance the magnitude of both CD8+ cytotoxic T lymphocytes (CTL) and antibody responses has clearly been demonstrated by our lab and others, but the influence of cytokines on protective immune responses is much less clear. Here we show an essential role for CD4+ Th1 helper cell induction and IFN-γ production in protection from viral challenge with a recombinant vaccinia virus expressing HIV-1MN viral envelope glycoprotein gp160. Complete protection from viral challenge is achieved only when the triple combination of exogenous cytokines granulocyte macrophage colony stimulating factor (GM-CSF), IL-12 and tumor necrosis factor (TNF)-α are co-administered with the peptide vaccine. In vivo depletion of CD4+ cells or immunization of IFN-γ-deficient mice abrogates protection. GM-CSF, IL-12 and TNF-α also synergize for the enhanced induction of CTL; however, adoptive transfer of a CD8+ CTL line afforded only partial protection in this viral challenge model. As a possible mechanism of in vivo protection we show that GM-CSF increases the percentage and activity of antigen-presenting dendritic cells in draining lymph nodes where the immune response is initiated. We further demonstrate synergy between IL-12 and the proinflammatory cytokine TNF-α in driving IFN-γ production. Thus, a combination of IL-12 and TNF-α is essential for the optimal development of Th1 responses and help for CTL induction in BALB/c mice, and is complemented by a third cytokine, GM-CSF, which enhances antigen presentation.</description><identifier>ISSN: 0953-8178</identifier><identifier>EISSN: 1460-2377</identifier><identifier>DOI: 10.1093/intimm/13.7.897</identifier><identifier>PMID: 11431420</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>AIDS Vaccines - immunology ; Amino Acid Sequence ; Animals ; Antigen-Presenting Cells - immunology ; APC antigen-presenting cell ; CD4 antigen ; CD4-Positive T-Lymphocytes - immunology ; CD40L CD40 ligand ; CTL cytotoxic T lymphocyte ; cytokines ; cytotoxic T lymphocyte ; Female ; GM-CSF granulocyte macrophage colony stimulating factor ; Granulocyte-Macrophage Colony-Stimulating Factor - immunology ; HIV Envelope Protein gp160 - immunology ; HIV-1 - immunology ; Human immunodeficiency virus 1 ; Humans ; Immunophenotyping ; Interferon-gamma - immunology ; Interleukin-12 - immunology ; ISA incomplete Seppic adjuvant ; Mice ; Mice, Inbred BALB C ; Mice, Knockout ; Molecular Sequence Data ; T-Lymphocytes, Cytotoxic - immunology ; Th1 cells ; Th1 Cells - immunology ; TNF tumor necrosis factor ; Tumor Necrosis Factor-alpha - immunology ; Vaccines, Synthetic - immunology ; viral immunity</subject><ispartof>International immunology, 2001-07, Vol.13 (7), p.897-908</ispartof><rights>Copyright Oxford University Press(England) Jul 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-4098071464cd8cc769ca0f7b1b1f91f27934cadf3748e0795c3e4732c9b86ca13</citedby><cites>FETCH-LOGICAL-c459t-4098071464cd8cc769ca0f7b1b1f91f27934cadf3748e0795c3e4732c9b86ca13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11431420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahlers, Jeffrey D.</creatorcontrib><creatorcontrib>Belyakov, Igor M.</creatorcontrib><creatorcontrib>Matsui, So</creatorcontrib><creatorcontrib>Berzofsky, Jay A.</creatorcontrib><title>Mechanisms of cytokine synergy essential for vaccine protection against viral challenge</title><title>International immunology</title><addtitle>Int. Immunol</addtitle><description>The ability of cytokines to steer CD4+ Th cell responses toward a Th1 or Th2 phenotype and enhance the magnitude of both CD8+ cytotoxic T lymphocytes (CTL) and antibody responses has clearly been demonstrated by our lab and others, but the influence of cytokines on protective immune responses is much less clear. Here we show an essential role for CD4+ Th1 helper cell induction and IFN-γ production in protection from viral challenge with a recombinant vaccinia virus expressing HIV-1MN viral envelope glycoprotein gp160. Complete protection from viral challenge is achieved only when the triple combination of exogenous cytokines granulocyte macrophage colony stimulating factor (GM-CSF), IL-12 and tumor necrosis factor (TNF)-α are co-administered with the peptide vaccine. In vivo depletion of CD4+ cells or immunization of IFN-γ-deficient mice abrogates protection. GM-CSF, IL-12 and TNF-α also synergize for the enhanced induction of CTL; however, adoptive transfer of a CD8+ CTL line afforded only partial protection in this viral challenge model. As a possible mechanism of in vivo protection we show that GM-CSF increases the percentage and activity of antigen-presenting dendritic cells in draining lymph nodes where the immune response is initiated. We further demonstrate synergy between IL-12 and the proinflammatory cytokine TNF-α in driving IFN-γ production. Thus, a combination of IL-12 and TNF-α is essential for the optimal development of Th1 responses and help for CTL induction in BALB/c mice, and is complemented by a third cytokine, GM-CSF, which enhances antigen presentation.</description><subject>AIDS Vaccines - immunology</subject><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antigen-Presenting Cells - immunology</subject><subject>APC antigen-presenting cell</subject><subject>CD4 antigen</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD40L CD40 ligand</subject><subject>CTL cytotoxic T lymphocyte</subject><subject>cytokines</subject><subject>cytotoxic T lymphocyte</subject><subject>Female</subject><subject>GM-CSF granulocyte macrophage colony stimulating factor</subject><subject>Granulocyte-Macrophage Colony-Stimulating Factor - immunology</subject><subject>HIV Envelope Protein gp160 - immunology</subject><subject>HIV-1 - immunology</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Interferon-gamma - immunology</subject><subject>Interleukin-12 - immunology</subject><subject>ISA incomplete Seppic adjuvant</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Knockout</subject><subject>Molecular Sequence Data</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><subject>Th1 cells</subject><subject>Th1 Cells - immunology</subject><subject>TNF tumor necrosis factor</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><subject>Vaccines, Synthetic - immunology</subject><subject>viral immunity</subject><issn>0953-8178</issn><issn>1460-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1vEzEQxS0EomnhzA2tOPS2iWdtZ-wjjUqDSFUhgUBcLMeZDW53va29qch_j6tEIHHhNIf3mzcfj7E3wKfAjZiFOIa-n4GY4lQbfMYmIOe8bgTiczbhRolaA-oTdprzLedcNEa8ZCcAUoBs-IR9uyb_08WQ-1wNbeX343AXIlV5Hylt9xXlTGWG66p2SNWj8_5JvU_DSH4MQ6zc1oWYx-oxpAIVr66juKVX7EXrukyvj_WMff1w-WWxrFc3Vx8X71e1l8qMteRGcyw7S7_R3uPceMdbXMMaWgNtg0ZI7zatQKmJo1FekETReLPWc-9AnLHzg29Z6WFHebR9yJ66zkUadtkiNwio1H9B0Fyr8pMCvvsHvB12KZYjLBjFhRLKFGh2gHwack7U2vsUepf2Frh9SsYekrEgLNqSTOl4e7TdrXva_OWPURSgPgAhj_Trj-7SnZ2jQGWX339YfQHLT4vVZ3shfgOaeJpK</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>Ahlers, Jeffrey D.</creator><creator>Belyakov, Igor M.</creator><creator>Matsui, So</creator><creator>Berzofsky, Jay A.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20010701</creationdate><title>Mechanisms of cytokine synergy essential for vaccine protection against viral challenge</title><author>Ahlers, Jeffrey D. ; Belyakov, Igor M. ; Matsui, So ; Berzofsky, Jay A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-4098071464cd8cc769ca0f7b1b1f91f27934cadf3748e0795c3e4732c9b86ca13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>AIDS Vaccines - immunology</topic><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antigen-Presenting Cells - immunology</topic><topic>APC antigen-presenting cell</topic><topic>CD4 antigen</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD40L CD40 ligand</topic><topic>CTL cytotoxic T lymphocyte</topic><topic>cytokines</topic><topic>cytotoxic T lymphocyte</topic><topic>Female</topic><topic>GM-CSF granulocyte macrophage colony stimulating factor</topic><topic>Granulocyte-Macrophage Colony-Stimulating Factor - immunology</topic><topic>HIV Envelope Protein gp160 - immunology</topic><topic>HIV-1 - immunology</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Interferon-gamma - immunology</topic><topic>Interleukin-12 - immunology</topic><topic>ISA incomplete Seppic adjuvant</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Knockout</topic><topic>Molecular Sequence Data</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><topic>Th1 cells</topic><topic>Th1 Cells - immunology</topic><topic>TNF tumor necrosis factor</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><topic>Vaccines, Synthetic - immunology</topic><topic>viral immunity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahlers, Jeffrey D.</creatorcontrib><creatorcontrib>Belyakov, Igor M.</creatorcontrib><creatorcontrib>Matsui, So</creatorcontrib><creatorcontrib>Berzofsky, Jay A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahlers, Jeffrey D.</au><au>Belyakov, Igor M.</au><au>Matsui, So</au><au>Berzofsky, Jay A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanisms of cytokine synergy essential for vaccine protection against viral challenge</atitle><jtitle>International immunology</jtitle><addtitle>Int. Immunol</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>13</volume><issue>7</issue><spage>897</spage><epage>908</epage><pages>897-908</pages><issn>0953-8178</issn><eissn>1460-2377</eissn><abstract>The ability of cytokines to steer CD4+ Th cell responses toward a Th1 or Th2 phenotype and enhance the magnitude of both CD8+ cytotoxic T lymphocytes (CTL) and antibody responses has clearly been demonstrated by our lab and others, but the influence of cytokines on protective immune responses is much less clear. Here we show an essential role for CD4+ Th1 helper cell induction and IFN-γ production in protection from viral challenge with a recombinant vaccinia virus expressing HIV-1MN viral envelope glycoprotein gp160. Complete protection from viral challenge is achieved only when the triple combination of exogenous cytokines granulocyte macrophage colony stimulating factor (GM-CSF), IL-12 and tumor necrosis factor (TNF)-α are co-administered with the peptide vaccine. In vivo depletion of CD4+ cells or immunization of IFN-γ-deficient mice abrogates protection. GM-CSF, IL-12 and TNF-α also synergize for the enhanced induction of CTL; however, adoptive transfer of a CD8+ CTL line afforded only partial protection in this viral challenge model. As a possible mechanism of in vivo protection we show that GM-CSF increases the percentage and activity of antigen-presenting dendritic cells in draining lymph nodes where the immune response is initiated. We further demonstrate synergy between IL-12 and the proinflammatory cytokine TNF-α in driving IFN-γ production. Thus, a combination of IL-12 and TNF-α is essential for the optimal development of Th1 responses and help for CTL induction in BALB/c mice, and is complemented by a third cytokine, GM-CSF, which enhances antigen presentation.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>11431420</pmid><doi>10.1093/intimm/13.7.897</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0953-8178
ispartof International immunology, 2001-07, Vol.13 (7), p.897-908
issn 0953-8178
1460-2377
language eng
recordid cdi_proquest_miscellaneous_70971755
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects AIDS Vaccines - immunology
Amino Acid Sequence
Animals
Antigen-Presenting Cells - immunology
APC antigen-presenting cell
CD4 antigen
CD4-Positive T-Lymphocytes - immunology
CD40L CD40 ligand
CTL cytotoxic T lymphocyte
cytokines
cytotoxic T lymphocyte
Female
GM-CSF granulocyte macrophage colony stimulating factor
Granulocyte-Macrophage Colony-Stimulating Factor - immunology
HIV Envelope Protein gp160 - immunology
HIV-1 - immunology
Human immunodeficiency virus 1
Humans
Immunophenotyping
Interferon-gamma - immunology
Interleukin-12 - immunology
ISA incomplete Seppic adjuvant
Mice
Mice, Inbred BALB C
Mice, Knockout
Molecular Sequence Data
T-Lymphocytes, Cytotoxic - immunology
Th1 cells
Th1 Cells - immunology
TNF tumor necrosis factor
Tumor Necrosis Factor-alpha - immunology
Vaccines, Synthetic - immunology
viral immunity
title Mechanisms of cytokine synergy essential for vaccine protection against viral challenge
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T17%3A49%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanisms%20of%20cytokine%20synergy%20essential%20for%20vaccine%20protection%20against%20viral%20challenge&rft.jtitle=International%20immunology&rft.au=Ahlers,%20Jeffrey%20D.&rft.date=2001-07-01&rft.volume=13&rft.issue=7&rft.spage=897&rft.epage=908&rft.pages=897-908&rft.issn=0953-8178&rft.eissn=1460-2377&rft_id=info:doi/10.1093/intimm/13.7.897&rft_dat=%3Cproquest_cross%3E18085142%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195035359&rft_id=info:pmid/11431420&rfr_iscdi=true